Financials Shijiazhuang Yiling Pharmaceutical Co., Ltd.

Equities

002603

CNE1000015S0

Pharmaceuticals

End-of-day quote Shenzhen S.E. 18:00:00 2024-07-18 EDT 5-day change 1st Jan Change
15.67 CNY -2.31% Intraday chart for Shijiazhuang Yiling Pharmaceutical Co., Ltd. +2.42% -32.08%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 14,801 30,365 32,746 50,054 38,543 26,213 - -
Enterprise Value (EV) 1 14,801 30,365 32,746 49,007 39,009 25,034 23,862 23,057
P/E ratio 24.9 x 25 x 24.4 x 21.2 x 28.5 x 17.1 x 12.9 x 12 x
Yield 1.61% 3.92% 1.53% 1.67% 1.3% 1.49% 2.31% 2.14%
Capitalization / Revenue 2.54 x 3.46 x 3.24 x 3.99 x 3.74 x 2.35 x 2.02 x 1.81 x
EV / Revenue 2.54 x 3.46 x 3.24 x 3.91 x 3.78 x 2.24 x 1.84 x 1.59 x
EV / EBITDA 15.2 x 17.7 x 16.9 x 15 x 16.8 x 10.1 x 7.44 x 7.31 x
EV / FCF - 68,745,950 x - - - - - -
FCF Yield - 0% - - - - - -
Price to Book 1.88 x 3.44 x 3.61 x 4.58 x 3.37 x 2.04 x 1.78 x 1.61 x
Nbr of stocks (in thousands) 1,667,081 1,667,081 1,670,705 1,670,705 1,670,705 1,670,705 - -
Reference price 2 8.879 18.21 19.60 29.96 23.07 15.67 15.67 15.67
Announcement Date 20-02-27 21-02-25 22-04-28 23-04-25 24-04-26 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 5,825 8,782 10,117 12,533 10,318 11,155 12,967 14,516
EBITDA 1 973.9 1,713 1,939 3,271 2,321 2,480 3,207 3,152
EBIT 1 710.2 1,438 1,569 2,830 1,780 1,925 2,493 2,721
Operating Margin 12.19% 16.37% 15.51% 22.58% 17.25% 17.26% 19.23% 18.75%
Earnings before Tax (EBT) 1 707.9 1,422 1,554 2,781 1,684 1,867 2,446 2,665
Net income 1 606.5 1,219 1,344 2,362 1,352 1,533 2,032 2,179
Net margin 10.41% 13.88% 13.28% 18.84% 13.11% 13.75% 15.67% 15.01%
EPS 2 0.3571 0.7286 0.8044 1.414 0.8095 0.9177 1.217 1.304
Free Cash Flow - 441.7 - - - - - -
FCF margin - 5.03% - - - - - -
FCF Conversion (EBITDA) - 25.79% - - - - - -
FCF Conversion (Net income) - 36.24% - - - - - -
Dividend per Share 2 0.1429 0.7143 0.3000 0.5000 0.3000 0.2341 0.3618 0.3359
Announcement Date 20-02-27 21-02-25 22-04-28 23-04-25 24-04-26 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - 466 - - -
Net Cash position 1 - - - 1,048 - 1,179 2,351 3,156
Leverage (Debt/EBITDA) - - - - 0.2005 x - - -
Free Cash Flow - 442 - - - - - -
ROE (net income / shareholders' equity) 7.83% 14.5% 14.9% 23.6% 12.2% 12.1% 13.9% 13.6%
ROA (Net income/ Total Assets) 6.88% 11.9% 11% 15.9% 7.96% 9.03% 10.7% 10.6%
Assets 1 8,813 10,281 12,199 14,864 16,979 16,987 19,015 20,595
Book Value Per Share 2 4.710 5.290 5.430 6.540 6.850 7.700 8.790 9.720
Cash Flow per Share 2 0.0400 0.9400 0.3200 2.090 0.0900 1.100 1.500 1.580
Capex 1 454 1,144 672 214 310 741 669 666
Capex / Sales 7.8% 13.03% 6.65% 1.7% 3% 6.64% 5.16% 4.59%
Announcement Date 20-02-27 21-02-25 22-04-28 23-04-25 24-04-26 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
15.67 CNY
Average target price
20.93 CNY
Spread / Average Target
+33.59%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 002603 Stock
  4. Financials Shijiazhuang Yiling Pharmaceutical Co., Ltd.